CTI BioPharma Corp. (CTIC): Price and Financial Metrics
CTI BioPharma Corp. (CTIC)
Today's Latest Price: $1.25 USD
0.07 (-5.30%)
Updated Feb 14 12:00am
Add CTIC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CTIC Stock Summary
- With a year-over-year growth in debt of -27.26%, Cti Biopharma Corp's debt growth rate surpasses merely 10.91% of about US stocks.
- Revenue growth over the past 12 months for Cti Biopharma Corp comes in at 45.19%, a number that bests 88.42% of the US stocks we're tracking.
- In terms of volatility of its share price, CTIC is more volatile than 88.02% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Cti Biopharma Corp, a group of peers worth examining would be QUIK, QTNT, RMBS, APVO, and DNN.
- Visit CTIC's SEC page to see the company's official filings. To visit the company's web site, go to www.ctibiopharma.com.
CTIC Daily Price Range
CTIC 52-Week Price Range
CTIC Stock Price Chart More Charts
CTIC Price/Volume Stats
| Current price | $1.25 | 52-week high | $1.93 |
| Prev. close | $1.32 | 52-week low | $0.63 |
| Day low | $1.25 | Volume | 193,300 |
| Day high | $1.34 | Avg. volume | 273,139 |
| 50-day MA | $1.34 | Dividend yield | N/A |
| 200-day MA | $0.94 | Market Cap | 72.47M |
CTI BioPharma Corp. (CTIC) Company Bio
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. The company was founded in 1991 and is based in Seattle, Washington.
Loading social stream, please wait...